Understanding weight loss in advanced cancer
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at how weight loss and muscle loss affect people with advanced cancer. It aims to find different types of weight loss to better guide treatment and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with advanced (stage 4) non-small cell lung, pancreatic, or colorectal cancer.
- You are planning to start or have just started your first cancer treatment (like chemo or immunotherapy) for this cancer.
- You have an ECOG performance status of 0, 1, or 2.
- You are 18 years or older and can read and speak English.
- You are not pregnant and do not have any planned major surgeries in the next 3 months.
- You do not have any other active cancer (except for non-melanoma skin cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.
This trial tests a treatment called postbiotics (which are helpful byproducts from good bacteria) to see if they can help reduce weight loss and muscle wasting in people with advanced lung cancer. If you have this type of cancer and have been losing weight, this study might offer a way to help you feel stronger and improve your quality of life.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This study tests whether a drug already approved for other cancers can help patients with advanced lung, pancreatic, or colorectal cancer who are losing weight. The drug may help improve appetite and weight stability.
This study explores why certain cancers cause patients to lose weight and muscle (called cancer cachexia) and tests ways to reverse it. Researchers will study tissue samples from patients with cancers of the food pipe, liver, stomach, or bile ducts to understand what's happening at a cellular level.
This study offers a weight management program for people with obesity who are undergoing active cancer treatment (chemo or radiation) for a solid tumor. It aims to help you manage your weight while you fight cancer, and requires living in the Barcelona area.
Hear when a new Advanced Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.